Home/Muvon Therapeutics/Dr. Christine Günther

DC

Dr. Christine Günther

Chief Technology Officer

Muvon Therapeutics

Therapeutic Areas

Urology Women's Health Regenerative Medicine

Muvon Therapeutics Pipeline

Drug	Indication	Phase
Autologous Muscle Precursor Cell Therapy	Stress Urinary Incontinence (SUI) in Women	Phase 2

Leadership Team at Muvon Therapeutics

Dr. Thomas Meier

Chairman of the Board of Directors

Likely Founder/CEO (based on award)

View full Muvon Therapeutics profile